论文部分内容阅读
目的观察氧气驱动雾化吸入万托林、爱全乐和普米克令舒治疗婴幼儿喘息性疾病(哮喘除外)的疗效。方法将93例以喘息为特征的患儿随机分为两组,对照组予抗病毒、抗生素抗感染,氨茶碱平喘、地塞米松抗炎及化痰、止咳等治疗,治疗组在对照组的基础上加用氧气驱动雾化吸入万托林0.4ml/次,(0.5ml=2.5mg硫酸沙丁胺醇)、爱全乐0.4～0.8ml/次,(1ml=0.25mg异丙托溴铵)、普米克令舒0.5mg/次,每天2～3次,疗程4～5天,对两组显效率及总有效率进行对比。结果治疗组显效率(81.25%)及总有效率(95.83%)明显高于对照组显效率(46.67%)及总有效率(73.33%),有显著差异(P<0.01)。结论氧气驱动雾化吸入万托林、爱全乐和普米克令舒治疗婴幼儿喘息性疾病效果显著。
Objective To observe the efficacy of aerosol driven inhalation of vaterol, AstraZeneca, and pulmicort in the treatment of infantile asthmatic diseases (except asthma). Methods Ninety-three children with wheezing were randomly divided into two groups. The control group was given anti-virus, anti-infective antibiotics, anti-asthma aminophylline, anti-inflammatory dexamethasone, (0.5ml = 2.5mg salbutamol sulphate), Aloe Vera 0.4 ~ 0.8ml / time, (1ml = 0.25mg ipratropium bromide) , Pulmicort respules 0.5mg / time, 2 to 3 times a day, the course of treatment 4 to 5 days, the two groups were markedly effective and the total effective rate was compared. Results The effective rate (81.25%) and total effective rate (95.83%) in the treatment group were significantly higher than those in the control group (46.67%) and the total effective rate (73.33%), with significant difference (P <0.01). Conclusion Oxygen-driven nebulization of vetomotol, AstraZeneca and pulmicort resuscitation treatment of infants with wheezing effect is significant.